Procedures to reveal ‘immunotoxic’ potentials of chemicals in animal experiments (mostly in rodents) have been recommended, but the selection of test systems is rather arbitrary. The predictive power of extrapolations to the possible situation in humans is unknown because human studies to confirm or to reject clues from animal data are largely lacking. End points selected in animal studies and those expected to be relevant in humans are not identical. Results of animal experiments are based on doses, generally ignoring the important species differences in pharmacokinetics. This unfavorable situation is especially pronounced when attempting to evaluate ‘environmental chemicals’. Because much more information is available on many medicinal drugs, exposures can be defined and pharmacokinetic data are available or obtainable. The situation is even more complicated when attempting to assess possible adverse effects on the developing immune system: in addition to the problems mentioned, numerous different developmental periods with varying susceptibilities must be considered, and species differences in the immune response are superimposed with large differences in pre-, early post-, and later postnatal development. Simultaneously, the kinetic variables are continuously changing with time (with additional variability among species). Different results, even between rats and mice, are bound to occur. Extrapolation to the situation possibly relevant for human exposure will be almost impossible, especially from rodent data. The majority of such effects induced peri-or early postnatally may be expected to be reversible. It must also be assessed whether qualitatively different adverse effects are likely to be induced during ‘development’, which cannot be revealed (accepting quantitative differences) by more easily performed tests on the adult organism. Considering the intrinsic difficulties, the most promising approach would be to directly obtain data from human trials. This is feasible for medicinal drugs. Alternatively, data on nonhuman primates, the species phylogenetically closest to man, may provide useful information. The status quo for such a strategy and the possible pitfalls are discussed in this overview.
Neubert D , Chahoud I . Possible consequences of preor perinatal exposure to substances with estrogenic or androgenic properties. In Gies A , Wenzel A eds. Endocrinically active chemicals in the environment. Berlin: Umweltbundesamt (ISSN 0722-186X) , 1996: 24–52, Texte 3/96.
2.
Neubert D.Vulnerability of the endocrine system to xenobiotic influence . Regul Toxicol Pharmacol1997; 26: 9–29 .
3.
Neubert D , Neubert R , Nogueira AC , Delgado I , Helge H , Dudenhausen JW . Immunological effects possibly induced in the pre-and perinatal period. In A Sund-wall , BR Danielsson , O Hagberg , E Lindgren , P Sjöberg , A Victor eds. Developmental toxicology, preclinical and clinical data in retrospect. Stockholm: Tryckgruppen , 1993: 67–77.
4.
Neubert R , Neubert D . Immune system. In Marquardt H , Schäfer SG , McClellan RO , Welsch F eds. Toxicology. San Diego: Academic Press (ISBN 0-12-473270-4) , 1999: 371–437.
5.
Neubert R , Helge H , Neubert D . Non-human primates as models for evaluating substance-induced changes in the immune system with relevance for man. In Smialowicz RJ , Holsapple M eds. Experimental immunotoxicology. Boca Raton: CRC Press , 1995: 63–98.
6.
Neubert R , Nogueira AC , Helge H , Stahlmann R , Neubert D . Feasibility of studying effects on the immune system in non-human primates. In Neubert D , Kavlock RJ , Merker H-J , Klein J eds. Risk assessment of prenatally-induced adverse health effects. Berlin: Springer-Verlag , 1992: 313–346.
7.
Neubert R , Golor G , Maskow L , Helge H , Neubert D . Evaluation of possible effects of 2,3,7,8-tetrachlorodi-benzo-p-dioxin and other congeners on lymphocyte receptors in Callithrix jacchus and man . Exp Clin Immunogenet1994; 11: 119–127 .
8.
Neubert R , Golor G , Helge H , Neubert D . Risk assessment for possible effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) and related substances on components and functions of the immune system . Exp Clin Immunogenet1994; 11: 163–171 .
9.
Foerster M , Delgado I , Abraham K , Gerstmayer S , Neubert R . Comparative study on age-dependent development of surface receptors on peripheral blood lymphocytes in children and young nonhuman primates (marmosets) . Life Sci1997; 60: 773–785 .
10.
Neubert R , Brambilla P , Gerthoux PM , Mocarelli P , Neubert D . Relevant data as well as limitations for assessing possible effects of polyhalogenated dibenzo-p-dioxins and dibenzofurans on the human immune system. In Ballrin-Denti A , Bertazzi PA , Facchetti SR , Fanelli R , Mocarelli P eds. Chemistry, man and environment, the Seveso accident 20 years on: monitoring, epidemiology and remediation. Amsterdam: Elsevier (ISBN 0-08-043644-7), 1999: 99–123.
11.
Neubert R , Nogueira AC , Neubert D . Thalidomide and the immune system: 2. Changes in receptors on blood cells of a healthy volunteer . Life Sci1992; 51: 2107–2117 .
12.
Nogueira AC , Neubert R , Helge H , Neubert D . Thalidomide and the immune system: 3. Simultaneous up-and down-regulation of different integrin receptors on human white blood cells . Life Sci1994; 55: 77–92 .
13.
Heger W , Neubert D . Maintenance and breeding of Callithrix jacchus in a colony in Berlin. In Neubert D , Merker H-J , Hendrickx AG eds. Non-human primates–developmental biology and toxicology. Wien, Berlin: Ueberreuter Wissenschaftsverlag , 1988: 53–64.
14.
Merker H-J , Sames K , Csato W , Heger W , Neubert D . The embryology of Callithrix jacchus. In Neubert D , Merker H-J , Hendrickx AG eds. Non-human primates–developmental biology and toxicology. Wien, Berlin: Ueberreuter Wissenschaftsverlag , 1988: 217–239.
15.
Neubert D , Heger W , Fischer B , Merker H-J . Variability and speed of development in marmosets as compared to man. In Neubert D , Merker H-J , Hendrickx AG eds. Non-human primates–developmental biology and toxicology. Wien, Berlin: Ueberreuter Wissenschaftsverlag , 1988: 205–215.
16.
Neubert R , Delgado I , Webb JR , et al. Assessing lymphocyte functions in neonates for revealing abnormal prenatal development of the immune system . Teratog Carcinog Mutagen2000; 20: 171–193 .
17.
Neubert R , Maskow L , Delgado I , Helge H , Neubert D . Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system: 2. In vitro proliferation of lymphocytes from workers with quantified moderately-increased body burdens . Life Sci1994/95; 56: 421–436 .
18.
Neubert R , Maskow L , Triebig G , et al. Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system: 3. Plasma immunoglobulins and cytokines of workers with quantified moderately-increased body burdens . Life Sci2000; 66: 2123–2142 .
19.
Thomas RM , Linch DC . Identification of lymphocyte subsets in the newborn using a variety of monoclonal antibodies . Arch Dis Child1983; 58: 34–38 .
20.
Griffiths-Chu S , Patterson AK , Berger CL , Edelson RL , Chu AC . Characterization of immature T cell subpopulations in neonatal blood . Blood1984; 64: 296–300 .
21.
Neubert R , Delgado I , Dudenhausen JW , Neubert D . Some data on the pattern of lymphocyte subsets in blood during the perinatal period. In Neubert D , Kavlock RJ , Merker H-J , Klein J eds. Risk assessment of prenatally-induced adverse health effects. Berlin: Springer-Verlag , 1992: 551–560.
22.
Erkeller-Yuksel FM , Deneys V , Yuksel B , et al. Agerelated changes in human blood lymphocyte populations . J Pediatr1992; 120: 216–222 .
23.
Kotny U , Barrachina C , Habermehl P , Mannhardt W , Zapp F , Shofer O . Distribution of lymphocyte surface antigens in healthy neonates . Eur J Pediatr1994; 153: 257–259 .
24.
Abraham K , Neubert R , Delgado I , Helge H , Neubert D . Altersabhängige Veränderungen von Adhäsionsmolekülen auf Lymphozyten bei Kindern . Monatsschr Kinderheilkd1994; 142: S142S142 (Abstract).
25.
Delgado I , Neubert R , Dudenhausen JW . Changes in white blood cells during parturition in mothers and newborn . Gynecol Obstet Invest1994; 38: 227–235 .
26.
Neubert R , Delgado I , Abraham K , Schuster C , Helge H . Evaluation of the age-dependent development of lymphocyte surface receptors in children . Life Sci1998; 62: 1099–1100 .
27.
Schulz T , Neubert D . Peculiarities of biotransformation in the pre-and postnatal period. In Ruckpaul K , Rein H eds. Frontiers in biotransformation: 9. Regulation and control of complex biological processes by biotransformation. Berlin: Akademie Verlag , 1993: 162–214.
28.
Smialowicz RJ , Riddle MM , Williams WC , Diliberto JJ . Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats . Toxicol Appl Pharmacol1994; 124: 248–256 .
29.
Neubert D.Risk assessment and preventive hazard minimization. In Marquardt H , Schäfer SG , McClellan RO , Welsch F eds. Toxicology. San Diego: Academic Press (ISBN 0-12-473270-4), 1999: 1153–1190.
30.
Neubert R , Foerster M , Nogueira AC , Helge H . Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset . Life Sci1995; 58: 317–324 .
31.
Schmidt S , Neubert R , Schmitt M , Neubert D . Studies on the immunoglobulin E system of the common marmoset in comparison with human data . Life Sci1996; 59: 719–730 .
32.
Neubert R , Helge H , Neubert D . Proliferative capacity of marmoset lymphocytes after tetanus vaccination and lack of 2,3,7,8-tetrachlorodibenzo-p-dioxin to reduce a booster effect . Life Sci1994/95; 56: 437–444 .
33.
Vos JG , van Loveren H , Schuurman H-J . Immunotoxicity of dioxins: immune function and host resistance in laboratory animals and humans . Banbury Rep1991; 35: 79–88 .
34.
Holsapple MP , Snyder NK , Wood SC , Morris DL . A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update . Toxicology1991; 69: 219–255 .
35.
Neubert D.Reflections on the assessment of the toxicity of ‘dioxins’ for humans, using data from experimental and epidemiological studies . Teratog Carcinog Mutagen1997/98; 17: 157–215 .
36.
Neubert R , Jacob-Müller U , Stahlmann R , Helge H , Neubert D . Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system: 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) . Arch Toxicol1990; 64: 345–359 .
37.
Neubert R , Helge H , Stahlmann R , Neubert D . Einige Wirkungen von 2,3,7,8-Tetrachlorodibenzo-p-dioxin (T4CDD) und von 2,3,4,7,8-Pentachlorodibenzofuran (P5CDF) auf periphere Lymphozyten von Primaten in vivo und in vitro . Allergologie1991; 14: 360–371 .
38.
Neubert R , Stahlmann R , Korte M , et al. Effects of small doses of dioxins on the immune system of marmosets and rats . Ann NY Acad Sci1993; 685: 662–686 .
39.
Neubert R , Golor G , Stahlmann R , Helge H , Neubert D . Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system: 4. Effects of multiple-dose treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) . Arch Toxicol1992; 66: 250–259 .
40.
Neubert R , Golor G , Stahlmann R , Helge H , Neubert D . Dose-dependent TCDD-induced increase or decrease in T-lymphocyte subsets in the blood of new world monkeys (Callithrix jacchus) . Chemosphere1992; 25: 1201–1206 .
41.
Pitot HC , Goldworthy TL , Moran S , et al. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose–response relationship to alter hepatic foci . Carcinogenesis1987; 8: 1491–1499 .
42.
Greenlee WF , Osborne R , Dold KM , Hudson LG , Young MJ , Toscano WA . Altered regulation of epidermal cell proliferation and differentiation by 2,3,7,8-TCDD . Rev Biochem Toxicol1987; 8: 1–35 .
43.
Panteleyev AA , Thiel R , Wanner R , et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin . J Invest Dermatol1997; 108: 330–335 .
44.
Webb KB , Evans RG , Knutsen AP , et al. Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin . J Toxicol Environ Health1989; 28: 183–193 .
45.
Evans RG , Webb KB , Knutsen AP , et al. A medical follow-up of the health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin . Arch Environ Health1988; 43: 273–278 .
46.
Ott MG , Zober A , Germann C . Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD . Chemosphere1994; 29: 2423–2437 .
47.
Zober MA , Ott MG , Päpke O , Senft K , Germann C . Morbidity study of extruder personnel with potential exposure to brominated dioxins and furans: I . Results of blood monitoring and immunological tests. Br J Ind Med1992; 49: 532532 .
48.
Neubert D , Neubert R , Brambilla P , Mocarelli P . Effects of dioxins in humans and correlation with animal data . Organohalog Compd1999; 42: 205–212 .
49.
Weisglas-Kuperus N , Sas TCJ , Koopman-Esseboom C , et al. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants . Pediatr Res1995; 38: 404–410 .
50.
Neubert R , Neubert D . Peculiarities and possible mode of the action of thalidomide. In Kavlock RJ , Daston GP eds. Drug toxicity in embryonic development: II. Handbook of experimental pharmacology, Volume 124 II. Berlin: Springer-Verlag , 1997: 44–119.
51.
Neubert D , Neubert R . The various facets of thalidomide . DGPT Forum1997; 21: 37–45 .
52.
Neubert R , Nogueira AC , Neubert D . Thalidomide derivatives and the immune system: I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood . Arch Toxicol1993; 67: 1–17 .
53.
Neubert R , Hinz N , Thiel R , Neubert D . Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide . Life Sci1995; 58: 295–316 .
54.
Neubert R , Hinz N , Thiel R . Embryonic development and surface integrin receptors. In Klug S , Thiel R eds. Methods in developmental toxicology/biology. Berlin: Blackwell , 1997: 209–226.
55.
Foerster M , Neubert R . Lack of effects on fetal thymus and lymphocyte development in marmoset fetuses and newborns following treatment with thalidomide . Teratology1995; 51: 23A–24A (Abstract).
56.
Thiel R , Foerster M , Stahlmann R , Neubert R . Effects of the thalidomide derivative EM12 on surface receptors of peripheral blood lymphocytes in Wistar rats . Teratology1995; 51: 30A–31A (Abstract).
57.
Thiel R , Kastner U , Neubert R . Expression of adhesion receptors on rat limb bud cells and results of treatment with a thalidomide derivative . Life Sci1999/2000; 66: 133–141 .
58.
Neubert D , B Jödicke , F Welsch . Reproduction and development. In Marquardt H , Schäfer SG , McClellan RO , Welsch F eds. Toxicology. San Diego, CA: Academic Press , 1997: 491–558.
59.
Dencker L , Hassoun E , d’Argy R , Alm G . Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners . Mol Pharmacol1985; 27: 133–140 .
60.
Foerster M , Kastner U , Neubert R . Effect of six virostatic nucleoside analogues on the development of fetal rat thymus in organ culture . Arch Toxicol1992; 66: 688–699 .
61.
Greenlee WF , Dold KM , Irons RD , Osborn R . Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin/ TCDD) on thymic epithelium . Toxicol Appl Pharmacol1985; 79: 112–120 .
62.
Riecke K , Klein U , Schmidt A , Baumannn-Wilschke I , Stahlmann R . Low concentrations of 2,3,7,8-tetrachloro-dibenzo-p-dioxin induce terminal differentiation of human thymic epithelial cells in vitro . Naunyn-Schmiedeberg's Arch Pharmacol2000; 361(Suppl 4): R149R149 (Abstract).
63.
Nau H , Neubert D . Development of drug-metabolizing monooxygenase systems in various mammalian species including man. Its significance for transplacental toxicity. In Neubert D , Merker H-J , Nau H , Langman J eds. Role of pharmacokinetics in prenatal and perinatal toxicology. Stuttgart: Georg Thieme Publishers , 1978: 13–44.
64.
Lewandowski C , Klug S , Nau H , Neubert D . Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture . Arch Toxicol1986; 58: 239–242 .
65.
Neubert D.Significance of pharmacokinetics for in vitro studies on teratogenesis. In Nau H , Scott WJ eds. Pharmacokinetics in teratogenesis, Volume II. Boca Raton, FL: CRC Press , 1987: 13–20.
66.
Descotes J.Immuno-toxicology of drugs and chemicals. Amsterdam: Elsevier , 1986.
